Is GW Pharmaceuticals publicly traded?
GW Pharmaceuticals shares (GWPH) are listed on the NASDAQ and all prices are listed in US Dollars. GW Pharmaceuticals employs 1,161 staff and has a trailing 12-month revenue of around 0.00.
What happened to GW Pharmaceuticals?
Jazz Pharmaceuticals (NASDAQ:JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (NASDAQ:GWPH). With the acquisition, Jazz gains access to GW’s cannabinoid portfolio, including Epidiolex, which raked in $510.5M in sales in 2020. …
Is GW Pharmaceuticals a good investment?
That resiliency combined with the company’s growth prospects make it a terrific investment to hang on to for years and years. And the recent drop in price only makes GW Pharmaceuticals stock an even better buy overall.
What is the stock symbol for GW Pharmaceuticals?
GWPH Related stocks
| Symbol | 3M %Chg |
|---|---|
| BSX | -7.32% |
| Boston Scientific Corp | |
| BAX | +5.65% |
| Baxter International Inc |
Is GW Pharmaceuticals an American company?
GW Pharmaceuticals is a British pharmaceutics company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country.
Who bought GW Pharma?
Jazz Pharmaceuticals
In the first marijuana industry buyout of 2021, Jazz Pharmaceuticals (NASDAQ:JAZZ) agreed to pay a hefty $7.6 billion to acquire GW Pharmaceuticals (NASDAQ:GWPH), a developer of cannabis-based medications.
Who bought Greenwich Pharmaceuticals?
Greenwich Biosciences, now a part of Jazz Pharmaceuticals, is the U.S. leader in the field of cannabinoid prescription medicines.
Who is buying GWPH?
A big merger at the intersection of the marijuana and pharmaceutical industries is one step closer to completion. On Friday, shareholders of GW Pharmaceuticals (NASDAQ:GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (NASDAQ:JAZZ), both companies announced in a joint press release.
Should I keep GWPH?
The consensus among Wall Street research analysts is that investors should “hold” GW Pharmaceuticals stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GWPH, but not buy additional shares or sell existing shares.
Who bought GWPH?
A big merger at the intersection of the marijuana and pharmaceutical industries is one step closer to completion. On Friday, shareholders of GW Pharmaceuticals (NASDAQ:GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (NASDAQ:JAZZ), both companies announced in a joint press release.
Who owns Jazz Pharmaceuticals?
Bruce C. Cozadd
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a biopharmaceutical company based in Ireland. It was founded in 2003….Jazz Pharmaceuticals.
| Type | Public company |
|---|---|
| Headquarters | Waterloo Exchange, Waterloo Road, D04 E5W7, Dublin, Ireland |
| Area served | Worldwide |
| Key people | Bruce C. Cozadd (Chairman & CEO) |
When did GW Pharmaceuticals plc report its earnings?
GW Pharmaceuticals plc (NASDAQ:GWPH) issued its quarterly earnings data on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.63) by $0.27.
What are the analysts ratings on GW Pharmaceuticals?
8 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for GW Pharmaceuticals in the last twelve months. There are currently 8 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should “hold” GW Pharmaceuticals stock.
What is the market capitalization of GW Pharmaceuticals?
GW Pharmaceuticals has a market capitalization of $6.86 billion and generates $311.33 million in revenue each year. The biopharmaceutical company earns $-9,020,000.00 in net income (profit) each year or ($0.24) on an earnings per share basis. How many employees does GW Pharmaceuticals have? GW Pharmaceuticals employs 1,161 workers across the globe.
What is the mailing address for GW Pharmaceuticals?
GW Pharmaceuticals’ mailing address is SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE X0, CB24 9BZ. The biopharmaceutical company can be reached via phone at 44-12-2326-6800 or via email at [email protected].